Triple
T19992939
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ebixa |
E494106
|
entity |
| Predicate | drugInteractionCaution |
P68633
|
FINISHED |
| Object | ketamine |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ketamine | Statement: [Ebixa, drugInteractionCaution, ketamine]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ketamine Context triple: [Ebixa, drugInteractionCaution, ketamine]
-
A.
DMT
DMT (N,N-Dimethyltryptamine) is a powerful, fast-acting psychedelic compound known for inducing intense, often mystical visual and emotional experiences and is found both in various plants and in trace amounts in the human body.
-
B.
Sibutad
Sibutad is a coastal municipality in the province of Zamboanga del Norte in the Philippines, known for its fishing communities and rural character.
-
C.
MDMA
MDMA, commonly known as ecstasy or molly, is a synthetic psychoactive drug that produces stimulant and hallucinogenic effects, often associated with heightened empathy, energy, and sensory perception.
-
D.
Kotramide
Kotramide was a medieval Armenian noblewoman known primarily as the wife of King Ashot I Bagratuni, the first king of the Bagratid Kingdom of Armenia.
-
E.
Trank
Trank is the surname of American film director and screenwriter Josh Trank, known for movies like "Chronicle" and "Fantastic Four."
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: ketamine Target entity description: Ketamine is a dissociative anesthetic medication that is also used at lower doses for rapid-acting treatment of depression and certain pain conditions, with notable psychoactive effects and abuse potential.
-
A.
DMT
DMT (N,N-Dimethyltryptamine) is a powerful, fast-acting psychedelic compound known for inducing intense, often mystical visual and emotional experiences and is found both in various plants and in trace amounts in the human body.
-
B.
Sibutad
Sibutad is a coastal municipality in the province of Zamboanga del Norte in the Philippines, known for its fishing communities and rural character.
-
C.
MDMA
MDMA, commonly known as ecstasy or molly, is a synthetic psychoactive drug that produces stimulant and hallucinogenic effects, often associated with heightened empathy, energy, and sensory perception.
-
D.
Kotramide
Kotramide was a medieval Armenian noblewoman known primarily as the wife of King Ashot I Bagratuni, the first king of the Bagratid Kingdom of Armenia.
-
E.
Trank
Trank is the surname of American film director and screenwriter Josh Trank, known for movies like "Chronicle" and "Fantastic Four."
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69da626a67648190af9653832a3aeced |
completed | April 11, 2026, 3:02 p.m. |
| NER | Named-entity recognition | batch_69e65fe2036c8190b9f313215ad44e87 |
completed | April 20, 2026, 5:18 p.m. |
Created at: April 11, 2026, 3:31 p.m.